On April 14, 2011, James Fan stood on a parking garage landing at Newark Liberty International Airport, a cheer-you-up letter from his young son in his pants pocket, the prospect of a four-story leap facing him.
Hours after Ken Frazier announced the biggest deal he’s made in three years as Merck & Co.’s leader, he cautioned investors not to expect any quick follow-ups.
Idenix Pharmaceuticals Inc. is undervalued by Merck & Co.’s $3.9 billion takeover offer, a shareholder said in a lawsuit seeking to block the deal.
Merck & Co., the second-biggest U.S. drugmaker by sales, beat analysts’ earnings estimates as the company cut spending on promotions and research.
The Prudential Center and Legends Hospitality signed a multiyear partnership that’ll help the Newark, New Jersey, venue become the first farm-to-table arena in the U.S.